As published by our group @BSACandJAC, #rifabutin, a #rifamycin available as #rifampin, has a great potential to be used in #bji and #prostheticjointinfection #pji as it is active at low dose against #staphaureus #persisters! 🔥
academic.oup.com/jac/jac/advanc…
0
0
0
0